Cost-Effectiveness of Blood Cultures for Adult Patients with Cellulitis
Authors:
Open Access
- 1 December 1999
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 29 (6) , 1483-1488
Abstract
To assess the cost-effectiveness of blood cultures for patients with cellulitis, a retrospective review was conducted of clinical and microbiologicalKeywords
This publication has 19 references indexed in Scilit:
- A Comparative Efficacy Trial in Germany in Infants Who Received Either the Lederle/Takeda Acellular Pertussis Component DTP (DTaP) Vaccine, the Lederle Whole-Cell Component DTP Vaccine, or DT VaccinePediatrics, 1998
- The impact of blood culture reporting and clinical liaison on the empiric treatment of bacteraemia.Journal of Clinical Pathology, 1997
- Analysis of 5 years of bacteraemias: Importance of stratification of microbial susceptibilities by source of patientsJournal of Infection, 1997
- IDCP GUIDELINES: SUPERFICIAL SKIN AND SOFT TISSUE INFECTIONSInfectious Diseases in Clinical Practice, 1997
- Severe community-acquired pneumonia: What do we need to know to effectively manage patients?Intensive Care Medicine, 1996
- Efficacy of blood cultures in the critically ill surgical patientSurgery, 1996
- Clinical Features and Aerobic and Anaerobic Microbiological Characteristics of CellulitisArchives of Surgery, 1995
- The Etiology of Bacterial Cellulitis as Determined by Fine-Needle AspirationScandinavian Journal of Infectious Diseases, 1989
- Non-group a beta-hemolytic streptococcal cellulitis. Association with venous and lymphatic compromiseThe American Journal of Medicine, 1985
- Group G Streptococcal Bacteremia: Clinical Study and Review of the LiteratureClinical Infectious Diseases, 1983